Suppression of ErbB2 breast tumors by MEDICA in ErbB2/neu mouse transgenes as well as in human ErbB2 breast cancer cells was accompanied by loss of plasma membrane ErbB2, together with other ErbB family members, including EGFR (ErbB1) and ErbB3. This evidence concerns the gene ERBB3 and breast cancer.